Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immatics N.V. - Ordinary Shares
(NQ:
IMTX
)
10.18
-1.69 (-14.24%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,649,444
Open
10.96
Bid (Size)
10.17 (800)
Ask (Size)
10.18 (10,300)
Prev. Close
11.87
Today's Range
9.910 - 10.96
52wk Range
3.300 - 12.41
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Immatics Announces $125 Million Underwritten Offering
Today 6:00 EST
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Third Quarter 2025 Financial Results and Business Update
November 17, 2025
From
https://immatics.com/
Via
GlobeNewswire
Performance
YTD
+37.2%
+37.2%
1 Month
+10.1%
+10.1%
3 Month
+78.0%
+78.0%
6 Month
+76.1%
+76.1%
1 Year
+27.7%
+27.7%
More News
Read More
Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
November 12, 2025
From
https://immatics.com/
Via
GlobeNewswire
Immatics Appoints Amie Krause as Chief People Officer
October 27, 2025
From
https://immatics.com/
Via
GlobeNewswire
Immatics Appoints Venkat Ramanan as Chief Financial Officer
October 01, 2025
From
https://immatics.com/
Via
GlobeNewswire
Adaptimmune Plunges After Announcing Nasdaq Delisting Amidst Compliance Failures and Cost-Cutting Measures
October 20, 2025
Via
MarketMinute
Topics
Initial Public Offering
Regulatory Compliance
Workforce
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
October 20, 2025
From
https://immatics.com/
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 02, 2025
Via
Benzinga
Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
August 19, 2025
Via
Benzinga
Immatics Announces Second Quarter 2025 Financial Results and Business Update
August 13, 2025
From
https://immatics.com/
Via
GlobeNewswire
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
May 31, 2025
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces First Quarter 2025 Financial Results and Business Update
May 13, 2025
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting
April 23, 2025
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Full Year 2024 Financial Results and Business Update
March 27, 2025
From
https://immatics.com/
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
January 03, 2025
Via
Benzinga
Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME
November 18, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME
November 08, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Pricing of $150 Million Public Offering
October 10, 2024
From
https://immatics.com/
Via
GlobeNewswire
Why Is Cancer-Focused Immatics Stock Trading Lower On Thursday?
↗
October 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 10, 2024
Via
Benzinga
Immatics Announces Proposed $150 Million Public Offering
October 10, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial
October 10, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024
October 04, 2024
From
https://immatics.com/
Via
GlobeNewswire
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
↗
October 01, 2024
Via
Talk Markets
Frequently Asked Questions
Is Immatics N.V. - Ordinary Shares publicly traded?
Yes, Immatics N.V. - Ordinary Shares is publicly traded.
What exchange does Immatics N.V. - Ordinary Shares trade on?
Immatics N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Immatics N.V. - Ordinary Shares?
The ticker symbol for Immatics N.V. - Ordinary Shares is IMTX on the Nasdaq Stock Market
What is the current price of Immatics N.V. - Ordinary Shares?
The current price of Immatics N.V. - Ordinary Shares is 10.18
When was Immatics N.V. - Ordinary Shares last traded?
The last trade of Immatics N.V. - Ordinary Shares was at 12/05/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today